PRKG1 and cardiac hypertrophy: found that miR‐374 inhibited the cardiac hypertrophy regression pathway by targeting vascular endothelial growth factor receptor 1 (VEGFR‐1) and PKG‐1.57 It is also reported that miR‐9 and miR‐98 were closely related to the development of myocardial hypertrophy.58 Furthermore, the decrease in miR‐133 might reduce endothelin‐1‐ and norepinephrine‐induced myocardial hypertrophy.59